Physician profile
Hanad Bashir
NPI 1437710779
$4,498.01
in general payments reported to CMS, 2019-2025
20 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $442 · 2023: $2,228 · 2024: $747 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523 · Travel and Lodging: $805 · Education: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,522.96 |
| Travel and Lodging | $805.38 |
| Education | $727.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,025.53 | 2023-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Atricure, INC. | $805.38 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $574.26 | 2022-2024 | Farxiga, Brilinta |
| Boston Scientific Corporation | $333.29 | 2025 | General - Vascular Access, Emerge Push |
| Inari Medical, INC. | $306.15 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $236.33 | 2025 | |
| Amgen INC. | $180.09 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.23 | 2023-2024 | Lifevest |
| Edwards Lifesciences Corporation | $158.85 | 2025 | |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Alnylam Pharmaceuticals INC. | $123.97 | 2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $120.83 | 2022 | |
| Medtronic, INC. | $90.38 | 2023-2024 | Corevalve Evolut R, Symplicity G3, Hvad Pump Implant Kit |
| Philips North America LLC | $59.31 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.53 | 2023-2024 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $37.80 | 2022-2023 | Definity |
| Bayer Healthcare Pharmaceuticals INC. | $30.24 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.89 | 2025 | Uptravi, Opsumit |
| Terumo Medical Corporation | $19.24 | 2025 | Heartrail, Metacross Otw, Glidesheath Slender |
| Pfizer INC. | $14.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanad Bashir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.